Corcept Therapeutics, Inc. (CORT)
33.87
-0.17
(-0.50%)
USD |
NASDAQ |
Mar 06, 16:00
33.88
+0.02
(+0.04%)
After-Hours: 20:00
Corcept Therapeutics SG&A Expense (TTM) : 448.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Axsome Therapeutics, Inc. | 570.60M |
| Alphatec Holdings, Inc. | 498.53M |
| Harrow, Inc. | 109.60M |
| Ultragenyx Pharmaceutical, Inc. | 350.06M |
| Amneal Pharmaceuticals, Inc. | 526.83M |